Aksjekurser for og nyheter om ProQR Therapeutics NV (PRQR) – Google Finance

Finance

StartsidePRQR • NASDAQ

ProQR Therapeutics NV

2,01 $

Før børsåpning:

2,01 $

(0,00 %)0,00

Stengt: 2. juli, 07:05:00 GMT-4 · USD · NASDAQ · Ansvarsfraskrivelse

Alnylam Pharmaceuticals, Inc.

322,06 $

ALNY1,24 %

Sangamo Therapeutics Inc

0,54 $

SGMO0,94 %

Outlook Therapeutics Inc

1,58 $

OTLK1,25 %

Axsome Therapeutics Inc

102,97 $

AXSM1,36 %

Cybin Inc

9,00 $

CYBN7,40 %

Uniqure NV

13,99 $

QURE0,36 %

Paysign Inc

7,38 $

PAYS2,50 %

Voyager Therapeutics Inc

3,12 $

VYGR0,32 %

Puma Biotechnology Inc

3,59 $

PBYI4,66 %

Wave Life Sciences Ltd

6,52 $

WVE0,23 %

AksjeVerdipapir notert i USA

Forrige sluttkurs

2,04 $

Dagsintervall

2,00 $ - 2,09 $

Årsintervall

1,07 $ - 4,62 $

Markedsverdi

211,48 mill. USD

Gjennomsnittlig volum

357,36k

P/E-tall

-

Utbytte

-

Hovedbørs

NASDAQ

Markedsnyheter

for 6 timer siden

Det viktigste å få med seg før børsen åpner

for 16 timer siden

Wall Street: Ordkrig sendte Tesla rett ned

for 1 time siden

Democrats, the last holdout bears, could be the key to a new stock-market rally

The Globe and Mail

for 1 time siden

The 3 Best-Performing S&P 500 Stocks of the Last 3 Years Have 1 Key Commonality Other Than Being AI Stocks. Can You Guess It?

Ledger Insights

for 52 minutter siden

S&P 500 Index licensed to Centrifuge, Janus Henderson for fund tokenization

for 1 time siden

Stock Market News: Dow Set to Open Higher After Senate Passes Spending Bill

Om

ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded in 2012 by chief executive officer Daniel A. de Boer. It specializes in the development of RNA therapeutics using its RNA editing platform technology called Axiomer. Wikipedia

Administrerende direktør

Daniel A. de Boer

Grunnlagt

2012

Nettsted

Ansatte

166

Søk

Slett søket

Lukk søkefunksjonen

Google-apper

Hovedmeny